Teva Pharmaceuticals (pty) Limited Pharmaceutical Import Profile — South Africa (DGFT 2022–2026)

Name: Teva Pharmaceuticals (pty) Limited Pharmaceutical Import Records from India — 2 Products, $7.1M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Teva Pharmaceuticals (pty) Limited — Pharmaceutical Importer Profile (2026) | 2 Products, $7.1M Trade | TransData Nexus

Teva Pharmaceuticals (pty) Limited

Pharmaceutical Importer · South Africa · Analgesics & Antipyretics Focus · $7.1M Total Trade · DGFT Verified

Teva Pharmaceuticals (pty) Limited is a pharmaceutical importer based in South Africa with a total trade value of $7.1M across 2 products in 2 therapeutic categories. Based on 157 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Teva Pharmaceuticals (pty) Limited sources from 2 verified Indian suppliers, with Adcock Ingram Limited accounting for 78.6% of imports.

Teva Pharmaceuticals (pty) Limited — Import Portfolio & Supplier Network

Teva Pharmaceuticals (pty) Limited import network — 2 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Teva Pharmaceuticals (pty) Limited?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Adcock Ingram Limited	$358.4K	9	78.6%
Centaur Pharmaceuticals Private Limited	$97.7K	2	21.4%

Teva Pharmaceuticals (pty) Limited sources from across .

What Formulations Does Teva Pharmaceuticals (pty) Limited Import?

Formulation	Value	Ships
Metformin teva er1000 MG/metformin hydrochloride extended release tablets1000 MG-6x10's -za Each extended release	$50.0K	1
Acurate tabletsparacetamol 450MG+doxylamine succinate5mg+caffeine30mg+codeine phosphate 10mg116880x2x20s	$50.0K	1
Acurate tabspara 450+doxylamine succinate5+caffeine30+codeine phosphate 10+colour quinoline yellow 2mg116960x2x20s	$50.0K	1
Acurate tabspara450mg+doxylamine succi5mg+caffeine 30MG+codeine phos10mg+quinoline yellow2mg2331.526kgs117280x2x20s	$50.0K	1
Acurate tabspara450mg+doxylamine succi5mg+caffeine 30MG+codeine phos10mg+quinoline yellow2mg2333.117kgs117360x2x20s	$50.0K	1
Acurate tabspara450mg+doxylamine succi5mg+caffeine 30MG+codeine phos10mg+quinoline yellow2mg1746.259kgs87840x2x20s	$50.0K	1
Metformin teva er 1000 MG/metformin hydrochloride extended release tablets 1000MG - 6x10's-za Each extended release TAB	$47.7K	1
Acurate tabspara450mg+doxylamine succi5mg+caffeine 30MG+codeine phos10mg+quinoline yellow2mg1162.582kgs58480x2x20s	$43.2K	1
Acurate tabspara450mg+doxylamine succi5mg+caffeine 30MG+codeine phos10mg+quinoline yellow2mg578.906kgs29120x2x20s	$22.1K	1
Acurate tabspara450mg+doxylamine succi5mg+caffeine 30MG+codeine phos10mg+quinoline yellow2mg580.496 kgs29200x2x20s	$21.6K	1
Acurate tabspara450mg+doxylamine succi5mg+caffeine 30MG+codeine phos10mg+quinoline yellow2mg580.496kgs29200x2x20s	$21.6K	1

Teva Pharmaceuticals (pty) Limited imports 11 distinct pharmaceutical formulations. Showing top 11 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 2 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Codeine	Analgesics & Antipyretics	$4.7M	109	3.4%	5
2	Caffeine	Respiratory & OTC	$2.4M	48	2.2%	4

Teva Pharmaceuticals (pty) Limited imports 2 pharmaceutical products across 2 categories into South Africa totaling $7.1M.

Teva Pharmaceuticals (pty) Limited — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Teva Pharmaceuticals (Pty) Limited is a subsidiary of Teva Pharmaceutical Industries Ltd., a global leader in generic and specialty medicines. Established in 1901 in Jerusalem, Teva has expanded its operations worldwide, including a significant presence in South Africa. The South African subsidiary is headquartered at 1st Floor, Building 3, Maxwell Office Park, Magwa Crescent West, Waterfall City, Midrand, Gauteng. (teva.co.za) As a pharmaceutical importer and buyer, Teva Pharmaceuticals (Pty) Limited plays a crucial role in the South African pharmaceutical distribution network, ensuring the availability of a diverse range of medicines to meet the country's healthcare needs.

2Distribution Network

Teva Pharmaceuticals (Pty) Limited operates a comprehensive distribution network within South Africa, with its central office located in Midrand, Gauteng. While specific details about additional warehouse locations and logistics capabilities are not publicly disclosed, Teva's global infrastructure supports efficient distribution channels. The company's extensive supply chain ensures that medicines are delivered promptly to various regions across South Africa, facilitating access to essential healthcare products nationwide.

3Industry Role

In the South African pharmaceutical supply chain, Teva Pharmaceuticals (Pty) Limited functions primarily as a pharmaceutical importer and buyer. By sourcing finished pharmaceutical formulations from international suppliers, including India, Teva ensures the availability of a wide array of medicines in the local market. This role is vital in maintaining a steady supply of both generic and specialty medicines, thereby contributing to the overall healthcare infrastructure of South Africa.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Teva Pharmaceuticals (pty) Limited

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Teva Pharmaceuticals (Pty) Limited's sourcing strategy reveals a notable concentration in its supplier base. The company has imported finished pharmaceutical formulations from two Indian suppliers:

ADCOCK INGRAM LIMITED: $358,000 across 9 shipments, accounting for 78.6% of the total import value.
CENTAUR PHARMACEUTICALS PRIVATE LIMITED: $98,000 across 2 shipments, representing 21.4% of the total import value.

This concentration indicates a strategic choice to maintain strong relationships with a select number of suppliers, potentially ensuring consistency in product quality and supply reliability. However, such dependency also poses risks, as any disruptions with these suppliers could significantly impact Teva's ability to meet market demand.

2Supply Chain Resilience

The resilience of Teva Pharmaceuticals (Pty) Limited's Indian supply chain is influenced by its reliance on a limited number of suppliers. While this focused approach may streamline operations, it also means that the company has limited backup suppliers to mitigate potential disruptions. The diversity of formulations imported—11 unique products across two therapeutic categories—provides some level of flexibility. However, the heavy reliance on a few suppliers underscores the importance of robust contingency planning and maintaining strong supplier relationships to ensure a resilient supply chain.

Importing Pharmaceuticals into South Africa — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for South Africa

1Regulatory Authority & Framework

In South Africa, the South African Health Products Regulatory Authority (SAHPRA) is the primary body responsible for regulating medicines and related substances. SAHPRA operates under the Medicines and Related Substances Act, 101 of 1965, as amended, which provides the legislative framework for the control of medicines, medical devices, and related substances. This act outlines the requirements for the registration, importation, and distribution of pharmaceutical products within the country. (sahpra.org.za)

2Import Licensing & GMP

To import pharmaceutical products into South Africa, companies must obtain a license from SAHPRA. This license is issued to manufacturers, wholesalers, or distributors and is contingent upon adherence to acceptable quality assurance principles and good manufacturing and distribution practices. Recognized Good Manufacturing Practice (GMP) certifications, such as EU GMP, WHO GMP, or PIC/S, are typically required to ensure that imported medicines meet the necessary quality standards. Additionally, wholesale distribution authorization is mandatory for entities involved in the distribution of pharmaceutical products within South Africa. (sahpra.org.za)

3Quality & Labeling

Teva Pharmaceuticals (pty) Limited — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Teva Pharmaceuticals (Pty) Limited's focus on importing finished pharmaceutical formulations in the therapeutic categories of Analgesics & Antipyretics and Respiratory & OTC products aligns with market demand in South Africa. Analgesics and antipyretics are essential for managing pain and fever, conditions prevalent across various demographics. Respiratory and over-the-counter products address common ailments such as colds, coughs, and other respiratory issues, which are widespread in the region. This strategic product selection ensures that Teva meets the immediate healthcare needs of the South African population.

2Sourcing Profile

Teva Pharmaceuticals (Pty) Limited's sourcing strategy emphasizes the importation of generic drug formulations, primarily from India. This approach leverages India's established reputation for producing high-quality, cost-effective generic medicines. The focus on finished formulations, rather than raw active pharmaceutical ingredients (APIs), indicates a preference for ready-to-market products that can be swiftly distributed within South Africa. This strategy aligns with Teva's global mission to provide accessible and affordable healthcare solutions.

3Market Positioning

Seller's Guide — How to Become a Supplier to Teva Pharmaceuticals (pty) Limited

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to enter Teva Pharmaceuticals (Pty) Limited's supply chain. The company's current sourcing pattern, characterized by a limited number of suppliers, suggests potential gaps that new entrants could fill. By meeting Teva's quality standards and regulatory requirements, Indian exporters can establish partnerships that enhance Teva's supply chain resilience and offer additional product options to the South African market.

2Requirements & Qualifications

Indian exporters aiming to supply Teva Pharmaceuticals (Pty) Limited and the South African market must adhere to several requirements. These include obtaining GMP certifications recognized by SAHPRA, such as EU GMP, WHO GMP, or PIC/S. Additionally, compliance with SAHPRA's import licensing regulations, quality assurance principles, and labeling standards is mandatory. Ensuring that products meet these criteria is essential for successful market entry and distribution within South Africa. (sahpra.org.za)

3How to Approach

Frequently Asked Questions — Teva Pharmaceuticals (pty) Limited

What products does Teva Pharmaceuticals (pty) Limited import from India?

Teva Pharmaceuticals (pty) Limited imports 2 pharmaceutical products across 2 categories. Top imports: Codeine ($4.7M), Caffeine ($2.4M).

Who supplies pharmaceuticals to Teva Pharmaceuticals (pty) Limited from India?

Teva Pharmaceuticals (pty) Limited sources from 2 verified Indian suppliers. The primary supplier is Adcock Ingram Limited (78.6% of imports, $358.4K).

What is Teva Pharmaceuticals (pty) Limited's total pharmaceutical import value?

Teva Pharmaceuticals (pty) Limited's total pharmaceutical import value from India is $7.1M, based on 157 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Teva Pharmaceuticals (pty) Limited focus on?

Teva Pharmaceuticals (pty) Limited imports across 2 categories. The largest: Analgesics & Antipyretics (66.0%), Respiratory & OTC (34.0%).

Get Full Teva Pharmaceuticals (pty) Limited Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Profile aggregates 4 company name variants from customs records. For current shipment-level data, contact TransData Nexus.